MedTrace Logo

Kybella for the Treatment of Flank Fat (FF)

NCT04841551 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-04-01

No results posted yet for this study

Summary

To Determine the safety and Effectiveness of Kybella for the treatment of Flank Fat (FF)

Conditions

  • Adiposity

Interventions

DRUG

Kybella Flanks

10 subjects will be treated with Kybella in the flanks

Sponsors & Collaborators

  • Beer, Kenneth R., M.D., PA

    lead INDIV

Principal Investigators

  • Kenneth Beer, M.D. · Research Institute of the Southeast, LLC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-22
Primary Completion
2022-03-02
Completion
2022-03-02
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04841551 on ClinicalTrials.gov